Genmab AS (GMAB) — Financial Flexibility Index
Genmab AS (GMAB) has a Financial Flexibility Index of 0.04x as of December 2025. Free cash flow of $313.32 Million (operating CF $300.34 Million minus capex $12.99 Million) represents 0% of total liabilities ($7.01 Billion). Also explore net asset momentum of Genmab AS to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genmab AS Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Genmab AS across 24 annual periods. Check Genmab AS (GMAB) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Genmab AS (2002–2025)
Year-by-year free cash flow to debt coverage for Genmab AS. For the full company profile including market capitalisation, see Genmab AS (GMAB) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | $1.22 Billion | $1.19 Billion | $7.01 Billion | ▼ -80.0% |
| 2024 | 0.87x | $7.96 Billion | $7.77 Billion | $9.11 Billion | ▼ -58.6% |
| 2023 | 2.11x | $7.76 Billion | $7.38 Billion | $3.68 Billion | ▲ +41.4% |
| 2022 | 1.49x | $4.23 Billion | $3.91 Billion | $2.84 Billion | ▲ +46.1% |
| 2021 | 1.02x | $2.48 Billion | $2.23 Billion | $2.43 Billion | ▼ -69.4% |
| 2020 | 3.33x | $6.74 Billion | $6.43 Billion | $2.02 Billion | ▲ +154.2% |
| 2019 | 1.31x | $1.44 Billion | $1.33 Billion | $1.10 Billion | ▼ -60.8% |
| 2018 | 3.34x | $1.49 Billion | $1.01 Billion | $446.64 Million | ▼ -34.1% |
| 2017 | 5.07x | $1.68 Billion | $1.59 Billion | $330.75 Million | ▲ +478.5% |
| 2016 | 0.88x | $360.83 Million | $327.72 Million | $411.54 Million | ▼ -18.4% |
| 2015 | 1.07x | $446.84 Million | $311.45 Million | $415.83 Million | ▲ +330.5% |
| 2014 | 0.25x | $208.11 Million | $132.67 Million | $833.74 Million | ▲ +327.5% |
| 2013 | -0.11x | $-117.63 Million | $-128.00 Million | $1.07 Billion | ▼ -279.8% |
| 2012 | 0.06x | $79.92 Million | $70.92 Million | $1.31 Billion | ▲ +115.3% |
| 2011 | -0.40x | $-430.02 Million | $-437.23 Million | $1.08 Billion | ▼ -300.9% |
| 2010 | 0.20x | $278.28 Million | $268.17 Million | $1.40 Billion | ▲ +133.2% |
| 2009 | -0.60x | $-553.28 Million | $-570.06 Million | $924.34 Million | ▼ -39.2% |
| 2008 | -0.43x | $-460.32 Million | $-513.33 Million | $1.07 Billion | ▼ -189.2% |
| 2007 | 0.48x | $518.74 Million | $505.90 Million | $1.08 Billion | ▲ +125.2% |
| 2006 | -1.92x | $-377.68 Million | $-379.62 Million | $197.05 Million | ▼ -133.9% |
| 2005 | -0.82x | $-206.21 Million | $-208.64 Million | $251.66 Million | ▲ +79.3% |
| 2004 | -3.95x | $-359.43 Million | $-367.70 Million | $90.92 Million | ▼ -28.7% |
| 2003 | -3.07x | $-287.66 Million | $-302.36 Million | $93.67 Million | ▼ -172.3% |
| 2002 | -1.13x | $-207.50 Million | $-308.32 Million | $183.97 Million | — |